<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Division of Psychiatry</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/27FEBC0F-8A74-49A7-A64F-AF63BEBA765A"><gtr:id>27FEBC0F-8A74-49A7-A64F-AF63BEBA765A</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Philip</gtr:otherNames><gtr:surname>Hunt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7218ABCD-9100-4326-BCAE-505E57986FA8"><gtr:id>7218ABCD-9100-4326-BCAE-505E57986FA8</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Curtis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/28D1D01E-DF6A-4AAE-9BDF-0E1013164105"><gtr:id>28D1D01E-DF6A-4AAE-9BDF-0E1013164105</gtr:id><gtr:firstName>Hugh Malcolm</gtr:firstName><gtr:surname>Gurling</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500791"><gtr:id>66B3DBD8-51C1-406E-A342-018F0CA87D3E</gtr:id><gtr:title>MOLECULAR GENETICS OF BIPOLAR AFFECTIVE DISORDER</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500791</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-02-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>297759</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts Institute of Technology (MIT)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Harvard UCL Lithium responsiveness collaboration</gtr:description><gtr:id>37602DD3-A3E3-47DF-A762-5B5F851F88B7</gtr:id><gtr:impact>Involves multidisciplinary team of clinicians, geneticists and statistician. Perlis, R.H., Smoller, J.W., Ferreira, M.A., McQuillin, A., Bass, N., Lawrence, J., Sachs, G.S., Nimgaonkar, V., Scolnick, E.M., Gurling, H., Sklar, P. &amp;amp; Purcell, S. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder, Am J Psychiatry 166, 718-25 (2009).</gtr:impact><gtr:outcomeId>ACECBC78B1B-2</gtr:outcomeId><gtr:partnerContribution>We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard.</gtr:partnerContribution><gtr:piContribution>We have used genome wide association genotype data and clinical data on treatment response to the antimanic drug lithium carbonate in bipolar disorder using the University College London bipolar disorder case control sample.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Harvard UCL Lithium responsiveness collaboration</gtr:description><gtr:id>C5761EA8-FEE2-4147-9911-8AA4FC287145</gtr:id><gtr:impact>Involves multidisciplinary team of clinicians, geneticists and statistician. Perlis, R.H., Smoller, J.W., Ferreira, M.A., McQuillin, A., Bass, N., Lawrence, J., Sachs, G.S., Nimgaonkar, V., Scolnick, E.M., Gurling, H., Sklar, P. &amp;amp; Purcell, S. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder, Am J Psychiatry 166, 718-25 (2009).</gtr:impact><gtr:outcomeId>ACECBC78B1B-4</gtr:outcomeId><gtr:partnerContribution>We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard.</gtr:partnerContribution><gtr:piContribution>We have used genome wide association genotype data and clinical data on treatment response to the antimanic drug lithium carbonate in bipolar disorder using the University College London bipolar disorder case control sample.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Institute of Mental Health (NIMH)</gtr:department><gtr:description>Harvard UCL Lithium responsiveness collaboration</gtr:description><gtr:id>8E93DE9B-E2F4-4F3D-B477-01E5C7974BA7</gtr:id><gtr:impact>Involves multidisciplinary team of clinicians, geneticists and statistician. Perlis, R.H., Smoller, J.W., Ferreira, M.A., McQuillin, A., Bass, N., Lawrence, J., Sachs, G.S., Nimgaonkar, V., Scolnick, E.M., Gurling, H., Sklar, P. &amp;amp; Purcell, S. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder, Am J Psychiatry 166, 718-25 (2009).</gtr:impact><gtr:outcomeId>ACECBC78B1B-3</gtr:outcomeId><gtr:partnerContribution>We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard.</gtr:partnerContribution><gtr:piContribution>We have used genome wide association genotype data and clinical data on treatment response to the antimanic drug lithium carbonate in bipolar disorder using the University College London bipolar disorder case control sample.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Harvard UCL Lithium responsiveness collaboration</gtr:description><gtr:id>8887E21B-3D59-4C7F-BCB8-09E0BA1A653E</gtr:id><gtr:impact>Involves multidisciplinary team of clinicians, geneticists and statistician. Perlis, R.H., Smoller, J.W., Ferreira, M.A., McQuillin, A., Bass, N., Lawrence, J., Sachs, G.S., Nimgaonkar, V., Scolnick, E.M., Gurling, H., Sklar, P. &amp;amp; Purcell, S. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder, Am J Psychiatry 166, 718-25 (2009).</gtr:impact><gtr:outcomeId>ACECBC78B1B-1</gtr:outcomeId><gtr:partnerContribution>We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard. We have replicated new findings on genes predicting response to lithium treatment in bipolar disorder in samples from UCL and Harvard.</gtr:partnerContribution><gtr:piContribution>We have used genome wide association genotype data and clinical data on treatment response to the antimanic drug lithium carbonate in bipolar disorder using the University College London bipolar disorder case control sample.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Psychiatric Genome Wide Association Study Consortium (PGC)</gtr:description><gtr:id>580D946A-32DA-4A12-AE10-4FA3CCACBD28</gtr:id><gtr:impact>The PGC collaboration has found new genes increasing susceptibility to bipolar affective disorder and has confirmed some that had previously been identified. Genes causing early onset and severe bipolar disorder have been identified. Ferreira, M.A., O'Donovan, M.C., Meng, Y.A., Jones, I.R., Ruderfer, D.M., Jones, L., Fan, J., Kirov, G., Perlis, R.H., Green, E.K., Smoller, J.W., Grozeva, D., Stone, J., Nikolov, I., Chambert, K., Hamshere, M.L., Nimgaonkar, V.L., Moskvina, V., Thase, M.E., Caesar, S., Sachs, G.S., Franklin, J., Gordon-Smith, K., Ardlie, K.G., Gabriel, S.B., Fraser, C., Blumenstiel, B., Defelice, M., Breen, G., Gill, M., Morris, D.W., Elkin, A., Muir, W.J., McGhee, K.A., Williamson, R., MacIntyre, D.J., MacLean, A.W., St, C.D., Robinson, M., Van Beck, M., Pereira, A.C., Kandaswamy, R., McQuillin, A., Collier, D.A., Bass, N.J., Young, A.H., Lawrence, J., Ferrier, I.N., Anjorin, A., Farmer, A., Curtis, D., Scolnick, E.M., McGuffin, P., Daly, M.J., Corvin, A.P., Holmans, P.A., Blackwood, D.H., Gurling, H.M., Owen, M.J., Purcell, S.M., Sklar, P. &amp;amp; Craddock, N. Nat Genet 40, 1056-8 (2008).</gtr:impact><gtr:outcomeId>4546FDFF129-1</gtr:outcomeId><gtr:partnerContribution>Genotyping of the UCL bipolar case control sample using microarrays. NIH grant money has enabled databases to be created for the PGC collaboration.</gtr:partnerContribution><gtr:piContribution>We have contributed DNA from a sub sample of bipolar cases and controls. We have had shared responsibilities for management of the consortium and data analysis of a very large genetic case control sample.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press releases</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>28CD854F-9A93-45A7-9B26-0E100D82A684</gtr:id><gtr:impact>Press releases to accompany two publications in Nature and Nature Genetics

Widespread press coverage internationally</gtr:impact><gtr:outcomeId>B1946ED4EA4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>C48E94B8-F165-4ADF-AEC2-23304872C565</gtr:id><gtr:outcomeId>9EA603343FE0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>365000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Stanley Medical Research Institute (SMRI), USA Grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Stanley Medical Research Institute (SMRI)</gtr:fundingOrg><gtr:id>F8E2538C-37BC-4FD0-90C0-5AB0F682E62B</gtr:id><gtr:outcomeId>6BD02AB8BF10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>902000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>14E08DCF-B843-4820-A3EF-9960109D49D6</gtr:id><gtr:outcomeId>WyQCPKMpAUL0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>New genetic effect in ADHD and bipolar disorder as diagnostic test and new treatment approach to these disorders</gtr:description><gtr:grantRef>G0500791</gtr:grantRef><gtr:id>BC58A9B1-5C98-4EA5-9153-848CB6DE719C</gtr:id><gtr:impact>New drug synthesised by MRC drug development unit at NIMR Mill Hill</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>BC32F9D3F42</gtr:outcomeId><gtr:patentId>WO2009130465</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>NK1R (TACR1) gene in bipolar affective disorder and ADHD</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Genetic findings in ADHD and Bipolar disorder supported further development of a drug targeting the NK1R receptor</gtr:description><gtr:id>229891A1-DF60-4DAF-B9B5-18A8D30448A9</gtr:id><gtr:impact>No direct impacts</gtr:impact><gtr:outcomeId>VnFbBhitTRc</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>TACR1 agonist</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Microarray genetic data</gtr:description><gtr:id>6D1F1BE9-8BEF-4CF6-A295-F4AE3D7F8E1A</gtr:id><gtr:impact>New understanding of biological factors in bipolar affective disorder</gtr:impact><gtr:outcomeId>446990503CE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genotype and clincal data on bipolar disorder</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>DNA and Clinical Phenotype data</gtr:description><gtr:id>924E160B-7F44-4C54-9522-A2AA4A91DE1B</gtr:id><gtr:impact>See publications listed elsewhere in this report</gtr:impact><gtr:outcomeId>316266991F5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Bipolar case control sample</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>21D71FCA-E1A0-49B9-BBE0-B0F450B4914C</gtr:id><gtr:title>Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd785ade4657e488449045aaa764dd18"><gtr:id>fd785ade4657e488449045aaa764dd18</gtr:id><gtr:otherNames>Kandaswamy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_540e141e1416c287a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09214A0A-7BAD-4DB6-8535-4FEA403179BB</gtr:id><gtr:title>DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd00b5751b792945e70ee187e8553402"><gtr:id>cd00b5751b792945e70ee187e8553402</gtr:id><gtr:otherNames>Hennah W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>5B22F943001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A69C5615-CA58-409F-B3F5-29523B2F1DBC</gtr:id><gtr:title>Exome sequence analysis and follow up genotyping implicates rare ULK1 variants to be involved in susceptibility to schizophrenia.</gtr:title><gtr:parentPublicationTitle>Annals of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fda2100b1b5abff7e5c09c078192c784"><gtr:id>fda2100b1b5abff7e5c09c078192c784</gtr:id><gtr:otherNames>Al Eissa MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0003-4800</gtr:issn><gtr:outcomeId>5a2fd75a47c327.42144523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63DE8CE7-9049-4970-95E9-4CA7DC6BB25A</gtr:id><gtr:title>Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87d8930691148c1bde635db4efe7697a"><gtr:id>87d8930691148c1bde635db4efe7697a</gtr:id><gtr:otherNames>McQuillin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>C709A29CD71</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>967FF5B3-5AA6-4B71-886F-8A5AEB1F0911</gtr:id><gtr:title>Genetic variation in the miR-708 gene and its binding targets in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Bipolar disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d990ef14e535b425800fed62133764af"><gtr:id>d990ef14e535b425800fed62133764af</gtr:id><gtr:otherNames>Fiorentino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1398-5647</gtr:issn><gtr:outcomeId>585d3906438251.06052036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E30C966A-4CC3-4BFE-B467-419CBA715375</gtr:id><gtr:title>Sequencing of the ANKYRIN 3 gene (ANK3) encoding ankyrin G in bipolar disorder reveals a non-conservative amino acid change in a short isoform of ankyrin G.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fac5f345b8b7382d8f43aa0a84d9af8"><gtr:id>4fac5f345b8b7382d8f43aa0a84d9af8</gtr:id><gtr:otherNames>Dedman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_15137_27_22328486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>635F1BAE-3D29-494A-A72C-22C187C6DE2B</gtr:id><gtr:title>Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>JAMA psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd785ade4657e488449045aaa764dd18"><gtr:id>fd785ade4657e488449045aaa764dd18</gtr:id><gtr:otherNames>Kandaswamy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-622X</gtr:issn><gtr:outcomeId>pm_15137_27_23575746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DDCC2A9-E309-47F6-9F7B-3F2E11815F14</gtr:id><gtr:title>Case-case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genes.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/286453d468f8f58017342839f6017501"><gtr:id>286453d468f8f58017342839f6017501</gtr:id><gtr:otherNames>Curtis D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>pm_15137_27_21057379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>093BA801-10AD-45B7-8D8B-6C404A756171</gtr:id><gtr:title>Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia.</gtr:title><gtr:parentPublicationTitle>Behavioral and brain functions : BBF</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89ab98ebc38fe55186f1fc18366901cd"><gtr:id>89ab98ebc38fe55186f1fc18366901cd</gtr:id><gtr:otherNames>Bass NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1744-9081</gtr:issn><gtr:outcomeId>8B1F2E2732D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED0356C0-3CD9-4A9E-803A-89417FD8C014</gtr:id><gtr:title>Support of association between BRD1 and both schizophrenia and bipolar affective disorder.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1088953188e262704083a53d4b8ea231"><gtr:id>1088953188e262704083a53d4b8ea231</gtr:id><gtr:otherNames>Nyegaard M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>D760C2F4245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFA24CF3-D143-4854-A063-D3270D71F40B</gtr:id><gtr:title>Genetic variant analysis of the putative regulatory regions of the LRRC7 gene in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d990ef14e535b425800fed62133764af"><gtr:id>d990ef14e535b425800fed62133764af</gtr:id><gtr:otherNames>Fiorentino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>585d65c43b7551.54190523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22420F7D-77EF-44A5-A695-64C48BB6D2B7</gtr:id><gtr:title>Tests of linkage and allelic association between markers in the 1p36 PRKCZ (protein kinase C zeta) gene region and bipolar affective disorder.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd785ade4657e488449045aaa764dd18"><gtr:id>fd785ade4657e488449045aaa764dd18</gtr:id><gtr:otherNames>Kandaswamy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_15137_27_22231931</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>951B22D0-A704-42A7-B1A7-6832748BC5C8</gtr:id><gtr:title>Association of rare variation in the glutamate receptor gene SLC1A2 with susceptibility to bipolar disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d990ef14e535b425800fed62133764af"><gtr:id>d990ef14e535b425800fed62133764af</gtr:id><gtr:otherNames>Fiorentino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>5675dce9eba24</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D637D15-EBC9-4735-94EA-07F4BEA7EA92</gtr:id><gtr:title>Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d773b2743e88bbbda8a4a2fb776c11"><gtr:id>a9d773b2743e88bbbda8a4a2fb776c11</gtr:id><gtr:otherNames>International Schizophrenia Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>332F4149FA0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F5B2057-6982-41E6-AD36-8695B66A97CF</gtr:id><gtr:title>Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80ce7cf57cec916411895deb0fc884fa"><gtr:id>80ce7cf57cec916411895deb0fc884fa</gtr:id><gtr:otherNames>Ferreira MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>30EBF20A2B0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FF52D60-9BA8-4D44-A6BF-1E879CFDBC61</gtr:id><gtr:title>Whole-genome association study of bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/421857724ad90f71312c3c715305777d"><gtr:id>421857724ad90f71312c3c715305777d</gtr:id><gtr:otherNames>Sklar P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>688C581D469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17D39A68-95AC-43E1-B6CC-EE0A497E0A62</gtr:id><gtr:title>CACNA1C hypermethylation is associated with bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e047dba5f5c4cb37e17b40d7fdb9acbc"><gtr:id>e047dba5f5c4cb37e17b40d7fdb9acbc</gtr:id><gtr:otherNames>Starnawska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>585d65c0a1a648.97882118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99E211BB-D296-4C85-B6BE-BE7EBBC29EA5</gtr:id><gtr:title>Hypomethylation of FAM63B in bipolar disorder patients.</gtr:title><gtr:parentPublicationTitle>Clinical epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e047dba5f5c4cb37e17b40d7fdb9acbc"><gtr:id>e047dba5f5c4cb37e17b40d7fdb9acbc</gtr:id><gtr:otherNames>Starnawska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1868-7075</gtr:issn><gtr:outcomeId>585d5018840018.08964267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09B96F15-418B-4FEF-8298-D9D878262D60</gtr:id><gtr:title>A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9be60215424a22a5df3f82c9ea88160c"><gtr:id>9be60215424a22a5df3f82c9ea88160c</gtr:id><gtr:otherNames>Perlis RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>FB4A0494151</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61634661-2380-4921-80C4-DC7AF495CA6F</gtr:id><gtr:title>Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9529512fa60d2e6005fd76375945e3bc"><gtr:id>9529512fa60d2e6005fd76375945e3bc</gtr:id><gtr:otherNames>Pereira AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_15137_27_21302346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>295135E1-1DCD-4ED3-B8D6-599AC8A35A88</gtr:id><gtr:title>The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e08eef1083248fa868790100035444d0"><gtr:id>e08eef1083248fa868790100035444d0</gtr:id><gtr:otherNames>O'Brien NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>doi_55faa1aa1cf7b31c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E780D36D-5B02-4A0C-A440-D35C90EDF1E3</gtr:id><gtr:title>Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data.</gtr:title><gtr:parentPublicationTitle>Bipolar disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d990ef14e535b425800fed62133764af"><gtr:id>d990ef14e535b425800fed62133764af</gtr:id><gtr:otherNames>Fiorentino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1398-5647</gtr:issn><gtr:outcomeId>doi_55faa1aa1d00dd1b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B620A74-B727-4040-9E3A-401B7CA775EE</gtr:id><gtr:title>Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02c18e63f80f85ded789fda5d6a3e178"><gtr:id>02c18e63f80f85ded789fda5d6a3e178</gtr:id><gtr:otherNames>Sharp SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_540e141e1417c1456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27FCA14F-03DB-4DAA-B6B4-439B825FA819</gtr:id><gtr:title>Association study of rare nonsynonymous variants of FTO in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1758c3916b6d5bb1c70f8da4d201940c"><gtr:id>1758c3916b6d5bb1c70f8da4d201940c</gtr:id><gtr:otherNames>Curtis JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>585d50002d4217.32646628</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500791</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>